Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Biogen Idec News

Home | Index > Business & Companies > Nasdaq 100 > Biogen Idec

TAKE THIS POLL
Is Belgian Prime Minister Herman Van Rompuy the right person to lead the EU as its president? (Nov. 20, 2009) Yes. No. Don't know.

Sort by: relevance (24 hours) relevance date

UPDATE 2-HealthCor slams Biogen CEO for outsize pay package 20 Nov 2009 20:23 GMT
... BOSTON, Nov 20 (Reuters) - Biogen Idec Inc ( ) shareholder HealthCor Management LP has slammed the biotech company's chief ...
UPDATE 1-HealthCor slams Biogen CEO for outsize pay package 20 Nov 2009 18:23 GMT
... * HealthCor criticizes Biogen CEO paycheck, stock sales * Calls on company to initiate sustained buyback program * ...
Biogen shareholder slams CEO pay, calls for measures to boost stock price 20 Nov 2009 19:54 GMT
... BIIB) board of directors, portfolio managers with called Mullen’s pay and incentives “inconsistent with Biogen Idec’s poor stock performance,” which is down nearly 3 percent year to date. Mullen ...
Biogen shareholders: CEO pay 'inconsistent' with poor stock performance 20 Nov 2009 20:13 GMT
... One of Biogen Idec Inc.’s largest investors is criticizing CEO James Mullen’s compensation package and other corporate ...
Genentech and Biogen Receive FDA Letter Over Rituxan 20 Nov 2009 04:34 GMT
... Genentech and Biogen Receive FDA Letter Over Rituxan Drug Discovery & Development - November 19, 2009 NEW ...

New Commander for Joint Task Force Afghanistan 20 Nov 2009 04:31 GMT
... New Commander for Joint Task Force Afghanistan New Commander ... Task Force Afghanistan was transferred from Brigadier-General (BGen) Jonathan Vance to BGen Daniel Menard during ...
Informant gets cash reward 20 Nov 2009 04:34 GMT
... CAMP BGEN OSCAR M FLORENDO, La Union – An informant, who gave information to the police ...
FDA Clears Way for Use of Rituxan for Leukemia 20 Nov 2009 06:58 GMT
... Clears Way for Use of Rituxan for Leukemia The FDA has approved Genentech and Biogen Idec's Rituxan plus chemotherapy for patients with untreated chronic lymphocytic leukemia (CLL), opening up ...
Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia 18 Nov 2009 21:36 GMT
... Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia ...
Genentech, Biogen Idec Receive Complete Response from FDA for Rituxan for CLL 19 Nov 2009 13:58 GMT
... Genentech, Biogen Idec Receive Complete Response from FDA for Rituxan for CLL 19 November 2009 - ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

Genentech, Biogen get FDA request on Rituxan 18 Nov 2009 22:12 GMT
... NEW YORK (AP) - Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration has asked for more information ...
Genentech, Biogen Idec get FDA request on application for Rituxan's use in leukemia 18 Nov 2009 23:37 GMT
... NEW YORK (AP) - Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration is withholding a decision to ...
Genentech, Biogen Idec get FDA request for more information on Rituxan's use in leukemia 18 Nov 2009 22:31 GMT
... ...
Genentech, Biogen get FDA request on Rituxan 18 Nov 2009 22:33 GMT
... ...
BRIEF-Genentech and Biogen get FDA complete response for Rituxan in chronic lymphocytic leukemia 18 Nov 2009 22:39 GMT
... ...
New Commander for Joint Task Force Afghanistan 19 Nov 2009 15:53 GMT
... OTTAWA (Marketwire) - Command of Joint Task Force ... Task Force Afghanistan was transferred from Brigadier-General (BGen) Jonathan Vance to BGen Daniel Menard during ...
New Commander for Joint Task Force Afghanistan (MRW) 19 Nov 2009 15:54 GMT
... New Commander for Joint Task Force Afghanistan OTTAWA, ONTARIO ... -- Command of was transferred from Brigadier-General (BGen) Jonathan Vance to BGen Daniel Menard during ...
US FDA issues complete response l... 19 Nov 2009 14:11 GMT
... issued a complete response to Genentech, a wholly-owned member of the Roche Group, and Biogen Idec (Nasdaq: BIIB) on the companies’ applications for Rituxan/MabThera (rituximab) plus fludarabine and cyclophosphamide ...
Icahn Reports New Stakes In Genzyme, Forest Labs At Sept 30 17 Nov 2009 01:32 GMT
... a quarterly filing with the Securities and Exchange Commission. Most of his largest holdings--including Biogen Idec Inc. (BIIB) and Motorola Inc. (MOT)--were unchanged in the quarter. Icahn reported a ...
Activity Jumps in Biotech and Drug Firms 18 Nov 2009 00:37 GMT
... NEW YORK—Shares of Biogen Idec took a dive last month, after a European health agency launched a review ...

THESE STORIES ARE NOT PUBLISHED BY IPD GROUP, INC. AND THESE LINKS WILL TAKE YOU TO OTHER WEBSITES. SOME OF THESE WEBSITES REQUIRE THEIR OWN REGISTRATION TO READ THEIR STORIES. PLEASE READ THE DISCLAIMER FOR MORE DETAILS. >>>

US regulator wants more information on Rituxan for CLL 19 Nov 2009 11:57 GMT
... US regulator wants more information on Rituxan for CLL Roche unit Genentech and Biogen Idec are going to have to wait a while before they can get expanded ...
Research and Markets: Cancer Therapies - Global Market Opportunities 19 Nov 2009 14:11 GMT
... and Other Countries -- GlaxoSmithKlines Cervarix Finds Place in UK National Immunization Programme -- Biogen Idec and Elan Commence Clinical Trial of TYSABRI -- GlaxoSmithKline Receives Conditional EU Approval ...
PanGenetics Announces Acquisition by Abbott of PG110 Anti-NGF Antibody to Treat Chronic Pain 17 Nov 2009 13:32 GMT
... in the technology and life-sciences sectors. For more information, please visit New Ventures is Biogen Idec's corporate venture group, which has a commitment of US$200 million for strategic investments ...
Nobel Laureate Claims the 2010 Herbert Tabor Lectureship 15 Nov 2009 11:54 GMT
... and Sciences and the American Philosophical Society. In addition, Sharp is a co-founder of Biogen (now known as Biogen Idec) and Alnylam Pharmaceuticals. The Herbert Tabor/Journal of Biological Chemistry ...
Sunesis Reports Financial Results for the Third Quarter of 2009 16 Nov 2009 13:34 GMT
... due to the completion of research funding and technology access fee amortization under the Biogen Idec collaboration in June 2008, partially offset by the recognition in the 2009 period ...